219 related articles for article (PubMed ID: 3982391)
1. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
Marks GS; Allen DT; Johnston CT; Sutherland EP; Nakatsu K; Whitney RA
Mol Pharmacol; 1985 Apr; 27(4):459-65. PubMed ID: 3982391
[TBL] [Abstract][Full Text] [Related]
2. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase.
McCluskey SA; Marks GS; Sutherland EP; Jacobsen N; Ortiz de Montellano PR
Mol Pharmacol; 1986 Oct; 30(4):352-7. PubMed ID: 3762522
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of 3-ethoxycarbonyl-1,4-dihydro-2,4-dimethylpyridine and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity and heme biosynthesis in chick embryo liver cells in culture.
Marks GS; Allen DT; Sutherland EP; McCluskey SA; Whitney RA
Can J Physiol Pharmacol; 1986 Apr; 64(4):483-6. PubMed ID: 3730932
[TBL] [Abstract][Full Text] [Related]
4. Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver.
Riddick DS; Park SS; Gelboin HV; Marks GS
Mol Pharmacol; 1989 May; 35(5):626-34. PubMed ID: 2725472
[TBL] [Abstract][Full Text] [Related]
5. Effects of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on hepatic cytochrome P-450 heme, apoproteins, and catalytic activities following in vivo administration to rats.
Riddick DS; Park SS; Gelboin HV; Marks GS
Mol Pharmacol; 1990 Jan; 37(1):130-6. PubMed ID: 2405248
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver.
Cole SP; Zelt DT; Marks GS
Mol Pharmacol; 1981 May; 19(3):477-80. PubMed ID: 7266472
[No Abstract] [Full Text] [Related]
7. Inactivation of cytochrome P450 and inhibition of ferrochelatase by analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine with 4-nonyl and 4-dodecyl substituents.
McCluskey SA; Riddick DS; Mackie JE; Kimmett SM; Whitney RA; Marks GS
Can J Physiol Pharmacol; 1992 Aug; 70(8):1069-74. PubMed ID: 1473038
[TBL] [Abstract][Full Text] [Related]
8. Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1, 4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.
Cole SP; Whitney RA; Marks GS
Mol Pharmacol; 1981 Sep; 20(2):395-403. PubMed ID: 7300820
[No Abstract] [Full Text] [Related]
9. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX.
McCluskey SA; Marks GS; Whitney RA; Ortiz de Montellano PR
Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143
[TBL] [Abstract][Full Text] [Related]
10. Isolation of an N-alkylprotoporphyrin IX from chick embryo livers following the administration of 3,5-diethoxycarbonyl-1,4-dihydro-4-ethyl-2,6-dimethylpyridine.
McCluskey SA; Sutherland EP; Racz WJ; Marks GS
Can J Physiol Pharmacol; 1987 Jul; 65(7):1500-2. PubMed ID: 3664364
[TBL] [Abstract][Full Text] [Related]
11. Effects of porphyrin-inducing drugs on ferrochelatase activity in isolated mouse hepatocytes.
Cole SP; Massey TE; Marks GS; Racz WJ
Can J Physiol Pharmacol; 1981 Nov; 59(11):1155-8. PubMed ID: 7317839
[TBL] [Abstract][Full Text] [Related]
12. Patterns of porphyrin accumulation in response to xenobiotics. Parallels between results in chick embryo and rodents.
Marks GS; Powles J; Lyon M; McCluskey S; Sutherland E; Zelt D
Ann N Y Acad Sci; 1987; 514():113-27. PubMed ID: 3126696
[TBL] [Abstract][Full Text] [Related]
13. Ferrochelatase and N-alkylated porphyrins.
Cole SP; Marks GS
Mol Cell Biochem; 1984 Sep; 64(2):127-37. PubMed ID: 6390167
[TBL] [Abstract][Full Text] [Related]
14. Isolation of regioisomers of N-alkylprotoporphyrin IX from chick embryo liver after treatment with porphyrinogenic xenobiotics.
Kobus SM; Wong SG; Marks GS
Can J Physiol Pharmacol; 2001 Sep; 79(9):814-21. PubMed ID: 11599783
[TBL] [Abstract][Full Text] [Related]
15. Synergistic induction of delta-aminolevulinic acid synthase activity by N-ethylprotoporphyrin IX and 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-isobutylpyridine .
Mackie JE; Marks GS
Biochem Pharmacol; 1989 Jul; 38(13):2169-73. PubMed ID: 2735955
[TBL] [Abstract][Full Text] [Related]
16. Patterns of porphyrin accumulation in response to chemicals in chick embryo liver cells.
Marks GS; Follows SB; Zelt DT; Cole SP
Can J Physiol Pharmacol; 1983 Jun; 61(6):546-53. PubMed ID: 6883207
[TBL] [Abstract][Full Text] [Related]
17. Irreversible binding of heme to microsomal protein during inactivation of cytochrome P450 by 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine.
Riddick DS; Marks GS
Biochem Pharmacol; 1990 Oct; 40(8):1915-21. PubMed ID: 2242024
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced porphyrin biosynthesis--XIX. Potentiation of the porphyrin-inducing effects of SKF 525-A in the chick embryo liver by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine, an antihibitor of ferrochelatase.
Cole SP; Vavasour EJ; Marks GS
Biochem Pharmacol; 1979 Dec; 28(24):0533-8. PubMed ID: 533555
[No Abstract] [Full Text] [Related]
19. Cytochrome P450 and its interactions with the heme biosynthetic pathway.
De Matteis F; Marks GS
Can J Physiol Pharmacol; 1996 Jan; 74(1):1-8. PubMed ID: 8963944
[TBL] [Abstract][Full Text] [Related]
20. Porphyrinogenic activity and ferrochelatase-inhibitory activity of sydnones in chick embryo liver cells.
Sutherland EP; Marks GS; Grab LA; Ortiz de Montellano PR
FEBS Lett; 1986 Mar; 197(1-2):17-20. PubMed ID: 3949013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
